Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
about
sameAs
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failureLorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditureDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionSerotonergic drugs and valvular heart diseaseDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsArterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertensionMolecular mechanisms of pulmonary arterial remodelingMicrovessel mechanobiology in pulmonary arterial hypertension: cause and effectTransglutaminase 2-mediated serotonylation in pulmonary hypertensionPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspectiveObesity: Current and potential pharmacotherapeutics and targets.Finding new tricks for old drugs: an efficient route for public-sector drug discovery.Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesAltered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension.Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine.Safety of antiobesity drugs.Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.Emerging pharmacotherapy for obesity.Recent advances in clinical practice challenges and opportunities in the management of obesity.Potential drug targets for calcific aortic valve disease.The potential use of selective 5-HT2C agonists in treating obesity.Smoking related diseases: the central role of monoamine oxidase.Functions of serotonin in hypoxic pulmonary vascular remodeling.Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.The use of serotonergic drugs to treat obesity--is there any hope?Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstrictionTrazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodone.The expanded biology of serotonin.Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertensionThrombosis, platelets, microparticles and PAH: more than a clot.Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formationPulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetusPulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertensionmiR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.
P2860
Q21245270-4F07EC89-B80B-4B1B-A8E9-42DB3D46D080Q21284504-C6CF78C6-C9B0-4448-B068-144CC13C70C1Q24611940-27AD264E-FD49-4C20-88B8-73D521B59422Q24641896-20DB55FB-4B84-4E81-AD7E-59C31082AFD9Q24646869-CBE63847-0478-4670-A30F-5BD9D97B5A75Q24647786-F435328B-35AE-40FD-9440-28F14E16A0CCQ24802101-C2AFAB39-B1F7-497C-A455-03D6C6FD8AE1Q26991806-A974FB82-48E5-40DC-B678-AE07BC98BD5BQ27009717-147A4927-FECA-4228-93FC-030861A97C16Q27027862-81425434-3FCE-4121-8FEB-568471550EE9Q27687091-DF12D107-6885-4571-9D35-C86CC58219ABQ28081115-15EF662D-8AC5-411B-8825-4598D6AA3CDDQ30243992-F580506F-F04A-4CAA-B1D7-BC41757FB1EBQ33229063-77E2D55B-3837-4672-B42F-40C37110A980Q33806247-3243E113-27D8-41CE-974B-8DCC40BB1EBBQ33849207-9CC29170-2ACB-4FE6-AEC6-1C03466545DEQ33862778-BFD53DD4-D894-4405-9A0A-669BB114D211Q33973748-BF520B07-8700-46F5-BB62-A4DAA1CE6BDDQ34016243-82483562-AB81-4251-A105-308ED1B3D7D5Q34087045-E1023AE2-9F1E-4B05-AEB0-7307D3EFB9ABQ34207458-3F4356E4-EEBD-4B33-8EAB-E3BF256E2E86Q34219768-670CCE48-9FFA-4279-9C5F-4016A0D1E850Q34399089-6961B8EA-D376-4DF6-AE17-B3374C884DA0Q34497896-EB01F8F3-9E24-4031-B964-32C7FE1EA298Q34566170-6FE4AB93-A8D2-4B3E-B1FB-F7BA8D248A41Q34653768-2C206BF0-1798-454E-B41B-1BAFAA92B2F5Q34661779-B8F5DB8C-ED0E-4453-BF7D-8687023AC161Q34712327-02388D71-FE1B-4EDE-AD96-024B25099FE6Q34913082-2C44D4EB-C610-44EF-9306-B8519C421126Q34977162-F09E71CA-3258-4306-BFFD-7475B4E5ACD3Q34993925-F3861768-26C2-4F87-9B76-B19B20E936D1Q35040806-A2119498-C816-48B7-9B20-468359B5AA94Q35276116-BF10272D-AF95-4C61-8CA4-664C49DE0F65Q35573424-63C7318B-D072-44E7-B8BF-74AA3444C2FDQ35601447-21A3AB06-EF29-4A88-A68B-C8FDFBF29623Q35665717-5121AB61-85FE-4949-A880-1AE1BC0F632AQ35850305-A7AEDCCA-7B7A-42A3-8CEF-715F4E5CD9B3Q35850316-BD4C8FDE-44EB-4280-AB1B-6101506CB780Q35919662-90B5F475-FDCE-49C4-8045-34222959DF2FQ36349894-D1C1948F-ED6A-4D39-A451-FD88F6B4A294
P2860
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@ast
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@en
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@nl
type
label
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@ast
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@en
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@nl
prefLabel
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@ast
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@en
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@nl
P2093
P2860
P50
P356
P1433
P1476
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
@en
P2093
C G Nebigil
C Tournois
G Simonneau
J Callebert
J-M Launay
P2860
P2888
P304
P356
10.1038/NM764
P407
P577
2002-10-01T00:00:00Z